Global Spatial Genomics Market Key Players Competitive Survey Report 2023
The global Spatial Genomics market size in 2022 is 204.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 11.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Spatial Genomics market include Thermo Fisher Scientific Inc. (U.S.), 10X Genomics (U.S.), NanoString Technologies Inc. (U.S.), Illumina Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.). The share of the top 3 players in the Spatial Genomics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Spatial Genomics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Fluorescence in situ hybridization (FISH) accounted for XX% of Spatial Genomics market in 2022. Microscopy-based Live DNA Imaging share of XX%.
Translational Research accounted for XX% of the Spatial Genomics market in 2022. Academic Customers accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Spatial Genomics market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Spatial Genomics market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Spatial Genomics market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Spatial Genomics market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Spatial Genomics industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some prominent players in the market includes:
Thermo Fisher Scientific Inc. (U.S.)
10X Genomics (U.S.)
NanoString Technologies Inc. (U.S.)
Illumina Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
QIAGEN (Netherlands)
Agilent Technologies, Inc. (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
S2 Genomics, Inc. (U.S.)
Seven Bridges Genomics (U.S.)
CARTANA AB (Sweden)
READCOOR, INC (U.S.)
Advanced Cell Diagnostics, Inc. (U.S.)
Dovetail Genomics (U.S.)
Novartis AG (Switzerland)
Pfizer Inc. (U.S.)
Merck & Co., Inc. (Germany)
Novo Nordisk A/S (Denmark)
Amgen Inc. (U.S.)
Johnson & Johnson Services, Inc. (U.S.)
Gsk plc (U.K.)
Bayer AG (Germany)
Market Data Breakdown by Type
Fluorescence in situ hybridization (FISH)
Microscopy-based Live DNA Imaging
Genome Perturbation Tools
Massively-Parallel Sequencing
Biochemical Techniques
Others
Market Data Breakdown by Applications
Translational Research
Academic Customers
Diagnostic Customers
Pharmaceutical Manufacturer
Government Institutes and Academic Centers
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Table of Content
1 Spatial Genomics Market Introduction and Overview
1.1 Spatial Genomics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Spatial Genomics Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Spatial Genomics Revenue and Market Share by Type
3 Global Spatial Genomics Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Spatial Genomics Revenue Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Spatial Genomics Market Size (2018-2023)
4.2 Spatial Genomics Growth Trends Analysis by Regions
4.2.1 Spatial Genomics Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Spatial Genomics Historic Revenue Market Size by Regions (2018-2023)
4.2.3 North America Spatial Genomics Market Size (2018-2023)
4.2.4 Europe Spatial Genomics Market Size (2018-2023)
4.2.5 Asia-Pacific Spatial Genomics Market Size (2018-2023)
4.2.6 Latin America Spatial Genomics Market Size (2018-2023)
4.2.7 Middle East & Africa Spatial Genomics Market Size (2018-2023)
5 North America
5.1 North America Spatial Genomics Revenue by Countries
5.1.1 North America Spatial Genomics Revenue by Countries (2018-2023)
5.2 North America Spatial Genomics Revenue by Types
5.3 North America Spatial Genomics Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Spatial Genomics Revenue by Countries
6.1.1 Asia Pacific Spatial Genomics Revenue by Countries (2018-2023)
6.2 Asia Pacific Spatial Genomics Revenue by Types
6.3 Asia Pacific Spatial Genomics Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Spatial Genomics Revenue by Countries
7.1.1 Europe Spatial Genomics Revenue by Countries (2018-2023)
7.2 Europe Spatial Genomics Revenue by Types
7.3 Europe Spatial Genomics Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Spatial Genomics Revenue by Countries
8.1.1 Latin America Spatial Genomics Revenue by Countries (2018-2023)
8.2 Latin America Spatial Genomics Revenue by Types
8.3 Latin America Spatial Genomics Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Spatial Genomics Revenue by Countries
9.1.1 Middle East & Africa Spatial Genomics Revenue by Countries (2018-2023)
9.2 Middle East & Africa Spatial Genomics Revenue by Types
9.3 Middle East & Africa Spatial Genomics Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Spatial Genomics Market Competition, by Players
10.1 Global Spatial Genomics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Spatial Genomics Players Market Share in 2022
10.2.2 Top 6 Spatial Genomics Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Spatial Genomics Players Head Office, Business Provided
10.4 Spatial Genomics Mergers & Acquisitions
10.5 Spatial Genomics New Entrants and Expansion Plans
11 Players Profiles11.1 Thermo Fisher Scientific Inc. (U.S.)
11.1.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile
11.1.2 Spatial Genomics Product Overview
11.1.3 Thermo Fisher Scientific Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.1.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 10X Genomics (U.S.)
11.2.1 10X Genomics (U.S.) Company Profile
11.2.2 Spatial Genomics Product Overview
11.2.3 10X Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.2.4 10X Genomics (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 NanoString Technologies Inc. (U.S.)
11.3.1 NanoString Technologies Inc. (U.S.) Company Profile
11.3.2 Spatial Genomics Product Overview
11.3.3 NanoString Technologies Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.3.4 NanoString Technologies Inc. (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Illumina Inc. (U.S.)
11.4.1 Illumina Inc. (U.S.) Company Profile
11.4.2 Spatial Genomics Product Overview
11.4.3 Illumina Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.4.4 Illumina Inc. (U.S.) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bio-Rad Laboratories, Inc. (U.S.)
11.5.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
11.5.2 Spatial Genomics Product Overview
11.5.3 Bio-Rad Laboratories, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.5.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 QIAGEN (Netherlands)
11.6.1 QIAGEN (Netherlands) Company Profile
11.6.2 Spatial Genomics Product Overview
11.6.3 QIAGEN (Netherlands) Spatial Genomics Market Performance (2018-2023)
11.6.4 QIAGEN (Netherlands) Business Overview
11.6.5 Recent Developments and Plans
11.7 Agilent Technologies, Inc. (U.S.)
11.7.1 Agilent Technologies, Inc. (U.S.) Company Profile
11.7.2 Spatial Genomics Product Overview
11.7.3 Agilent Technologies, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.7.4 Agilent Technologies, Inc. (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 F. Hoffmann-La Roche Ltd. (Switzerland)
11.8.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
11.8.2 Spatial Genomics Product Overview
11.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Spatial Genomics Market Performance (2018-2023)
11.8.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
11.8.5 Recent Developments and Plans
11.9 S2 Genomics, Inc. (U.S.)
11.9.1 S2 Genomics, Inc. (U.S.) Company Profile
11.9.2 Spatial Genomics Product Overview
11.9.3 S2 Genomics, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.9.4 S2 Genomics, Inc. (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Seven Bridges Genomics (U.S.)
11.10.1 Seven Bridges Genomics (U.S.) Company Profile
11.10.2 Spatial Genomics Product Overview
11.10.3 Seven Bridges Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.10.4 Seven Bridges Genomics (U.S.) Business Overview
11.10.5 Recent Developments and Plans
11.11 CARTANA AB (Sweden)
11.11.1 CARTANA AB (Sweden) Company Profile
11.11.2 Spatial Genomics Product Overview
11.11.3 CARTANA AB (Sweden) Spatial Genomics Market Performance (2018-2023)
11.11.4 CARTANA AB (Sweden) Business Overview
11.11.5 Recent Developments and Plans
11.12 READCOOR, INC (U.S.)
11.12.1 READCOOR, INC (U.S.) Company Profile
11.12.2 Spatial Genomics Product Overview
11.12.3 READCOOR, INC (U.S.) Spatial Genomics Market Performance (2018-2023)
11.12.4 READCOOR, INC (U.S.) Business Overview
11.12.5 Recent Developments and Plans
11.13 Advanced Cell Diagnostics, Inc. (U.S.)
11.13.1 Advanced Cell Diagnostics, Inc. (U.S.) Company Profile
11.13.2 Spatial Genomics Product Overview
11.13.3 Advanced Cell Diagnostics, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.13.4 Advanced Cell Diagnostics, Inc. (U.S.) Business Overview
11.13.5 Recent Developments and Plans
11.14 Dovetail Genomics (U.S.)
11.14.1 Dovetail Genomics (U.S.) Company Profile
11.14.2 Spatial Genomics Product Overview
11.14.3 Dovetail Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.14.4 Dovetail Genomics (U.S.) Business Overview
11.14.5 Recent Developments and Plans
11.15 Novartis AG (Switzerland)
11.15.1 Novartis AG (Switzerland) Company Profile
11.15.2 Spatial Genomics Product Overview
11.15.3 Novartis AG (Switzerland) Spatial Genomics Market Performance (2018-2023)
11.15.4 Novartis AG (Switzerland) Business Overview
11.15.5 Recent Developments and Plans
11.16 Pfizer Inc. (U.S.)
11.16.1 Pfizer Inc. (U.S.) Company Profile
11.16.2 Spatial Genomics Product Overview
11.16.3 Pfizer Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.16.4 Pfizer Inc. (U.S.) Business Overview
11.16.5 Recent Developments and Plans
11.17 Merck & Co., Inc. (Germany)
11.17.1 Merck & Co., Inc. (Germany) Company Profile
11.17.2 Spatial Genomics Product Overview
11.17.3 Merck & Co., Inc. (Germany) Spatial Genomics Market Performance (2018-2023)
11.17.4 Merck & Co., Inc. (Germany) Business Overview
11.17.5 Recent Developments and Plans
11.18 Novo Nordisk A/S (Denmark)
11.18.1 Novo Nordisk A/S (Denmark) Company Profile
11.18.2 Spatial Genomics Product Overview
11.18.3 Novo Nordisk A/S (Denmark) Spatial Genomics Market Performance (2018-2023)
11.18.4 Novo Nordisk A/S (Denmark) Business Overview
11.18.5 Recent Developments and Plans
11.19 Amgen Inc. (U.S.)
11.19.1 Amgen Inc. (U.S.) Company Profile
11.19.2 Spatial Genomics Product Overview
11.19.3 Amgen Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.19.4 Amgen Inc. (U.S.) Business Overview
11.19.5 Recent Developments and Plans
11.20 Johnson & Johnson Services, Inc. (U.S.)
11.20.1 Johnson & Johnson Services, Inc. (U.S.) Company Profile
11.20.2 Spatial Genomics Product Overview
11.20.3 Johnson & Johnson Services, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.20.4 Johnson & Johnson Services, Inc. (U.S.) Business Overview
11.20.5 Recent Developments and Plans
11.21 Gsk plc (U.K.)
11.21.1 Gsk plc (U.K.) Company Profile
11.21.2 Spatial Genomics Product Overview
11.21.3 Gsk plc (U.K.) Spatial Genomics Market Performance (2018-2023)
11.21.4 Gsk plc (U.K.) Business Overview
11.21.5 Recent Developments and Plans
11.22 Bayer AG (Germany)
11.22.1 Bayer AG (Germany) Company Profile
11.22.2 Spatial Genomics Product Overview
11.22.3 Bayer AG (Germany) Spatial Genomics Market Performance (2018-2023)
11.22.4 Bayer AG (Germany) Business Overview
11.22.5 Recent Developments and Plans
12 Global Spatial Genomics Forecast Market Analysis by Type
12.1 Global Spatial Genomics Revenue Market Forecast by Type (2023-2029)
13 Global Spatial Genomics Forecast Market Analysis by Application
13.1 Spatial Genomics Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Spatial Genomics Forecast Market Size (2023-2029)
14.2 Spatial Genomics Growth Trends Forecast Analysis by Regions
14.2.1 Spatial Genomics Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Spatial Genomics Forecast Market Size (2023-2029)
14.2.3 Europe Spatial Genomics Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Spatial Genomics Forecast Market Size (2023-2029)
14.2.5 Latin America Spatial Genomics Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Spatial Genomics Forecast Market Size (2023-2029)
15 Spatial Genomics Industry Dynamic Analysis
15.1 Spatial Genomics Market Trends Analysis
15.2 Spatial Genomics Market Drivers Analysis
15.3 Spatial Genomics Market Challenges Analysis
15.4 Spatial Genomics Market Restraints Analysis
List of Tables and Figures
Figure Spatial Genomics Picture
Table Product Definition of Spatial Genomics
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Spatial Genomics Market Size by Type (2018 VS 2023 VS 2029)
Table Global Spatial Genomics Revenue and Market Size by Type (2018-2023)
Table Global Spatial Genomics Revenue and Market Share by Type (2018-2023)
Table Global Spatial Genomics Market Size by Application (2018 VS 2023 VS 2029)
Table Global Spatial Genomics Revenue Market Size by Application (2018-2023)
Table Global Spatial Genomics Revenue Market Share by Application (2018-2023)
Figure Global Spatial Genomics Revenue Market Size (2018-2023)
Table Spatial Genomics Market Size by Regions: 2018 VS 2023 VS 2029
Table Spatial Genomics Historic Revenue Market Size by Regions (2018-2023)
Table Spatial Genomics Historic Revenue Market Share by Regions (2018-2023)
Figure North America Spatial Genomics Market Size (2018-2023)
Figure Europe Spatial Genomics Market Size (2018-2023)
Figure Asia-Pacific Spatial Genomics Market Size (2018-2023)
Figure Latin America Spatial Genomics Market Size (2018-2023)
Figure Middle East & Africa Spatial Genomics Market Size (2018-2023)
Table North America Spatial Genomics Revenue by Countries (2018-2023)
Table North America Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table North America Spatial Genomics Revenue by Types (2018-2023)
Table North America Spatial Genomics Revenue Market Share by Types (2018-2023)
Table North America Spatial Genomics Revenue by Applications (2018-2023)
Table North America Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure United States Spatial Genomics Revenue and Growth (2018-2023)
Figure Canada Spatial Genomics Revenue and Growth (2018-2023)
Table Asia-Pacific Spatial Genomics Revenue by Countries (2018-2023)
Table Asia-Pacific Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Asia Pacific Spatial Genomics Revenue by Types (2018-2023)
Table Asia Pacific Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Asia Pacific Spatial Genomics Revenue by Applications (2018-2023)
Table Asia Pacific Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure China Spatial Genomics Revenue and Growth (2018-2023)
Figure Japan Spatial Genomics Revenue and Growth (2018-2023)
Figure Korea Spatial Genomics Revenue and Growth (2018-2023)
Figure Southeast Asia Spatial Genomics Revenue and Growth (2018-2023)
Figure India Spatial Genomics Revenue and Growth (2018-2023)
Figure Australia Spatial Genomics Revenue and Growth (2018-2023)
Table Europe Spatial Genomics Revenue by Countries (2018-2023)
Table Europe Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Europe Spatial Genomics Revenue by Types (2018-2023)
Table Europe Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Europe Spatial Genomics Revenue by Applications (2018-2023)
Table Europe Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure Germany Spatial Genomics Revenue and Growth (2018-2023)
Figure France Spatial Genomics Revenue and Growth (2018-2023)
Figure UK Spatial Genomics Revenue and Growth (2018-2023)
Figure Italy Spatial Genomics Revenue and Growth (2018-2023)
Figure Russia Spatial Genomics Revenue and Growth (2018-2023)
Figure Spain Spatial Genomics Revenue and Growth (2018-2023)
Figure Nordic Spatial Genomics Revenue and Growth (2018-2023)
Table Latin America Spatial Genomics Revenue by Countries (2018-2023)
Table Latin America Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Latin America Spatial Genomics Revenue by Types (2018-2023)
Table Latin America Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Latin America Spatial Genomics Revenue by Applications (2018-2023)
Table Latin America Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure Brazil Spatial Genomics Revenue and Growth (2018-2023)
Figure Argentina Spatial Genomics Revenue and Growth (2018-2023)
Figure Mexico Spatial Genomics Revenue and Growth (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue by Countries (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue by Types (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue by Applications (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure Egypt Spatial Genomics Revenue and Growth (2018-2023)
Figure South Africa Spatial Genomics Revenue and Growth (2018-2023)
Figure UAE Spatial Genomics Revenue and Growth (2018-2023)
Figure Turkey Spatial Genomics Revenue and Growth (2018-2023)
Figure Saudi Arabia Spatial Genomics Revenue and Growth (2018-2023)
Table Global Spatial Genomics Revenue by Players (2018-2023)
Table Global Spatial Genomics Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Spatial Genomics Players Market Concentration Ratio (CR5) (2018-2023)
Table Spatial Genomics Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Thermo Fisher Scientific Inc. (U.S.) Profile
Table Product Overview
Table Thermo Fisher Scientific Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Thermo Fisher Scientific Inc. (U.S.) Revenue and Growth Rate
Figure Thermo Fisher Scientific Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table 10X Genomics (U.S.) Profile
Table Product Overview
Table 10X Genomics (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure 10X Genomics (U.S.) Revenue and Growth Rate
Figure 10X Genomics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table NanoString Technologies Inc. (U.S.) Profile
Table Product Overview
Table NanoString Technologies Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure NanoString Technologies Inc. (U.S.) Revenue and Growth Rate
Figure NanoString Technologies Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Illumina Inc. (U.S.) Profile
Table Product Overview
Table Illumina Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Illumina Inc. (U.S.) Revenue and Growth Rate
Figure Illumina Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bio-Rad Laboratories, Inc. (U.S.) Profile
Table Product Overview
Table Bio-Rad Laboratories, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue and Growth Rate
Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table QIAGEN (Netherlands) Profile
Table Product Overview
Table QIAGEN (Netherlands) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure QIAGEN (Netherlands) Revenue and Growth Rate
Figure QIAGEN (Netherlands) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Agilent Technologies, Inc. (U.S.) Profile
Table Product Overview
Table Agilent Technologies, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Agilent Technologies, Inc. (U.S.) Revenue and Growth Rate
Figure Agilent Technologies, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd. (Switzerland) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table S2 Genomics, Inc. (U.S.) Profile
Table Product Overview
Table S2 Genomics, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure S2 Genomics, Inc. (U.S.) Revenue and Growth Rate
Figure S2 Genomics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Seven Bridges Genomics (U.S.) Profile
Table Product Overview
Table Seven Bridges Genomics (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Seven Bridges Genomics (U.S.) Revenue and Growth Rate
Figure Seven Bridges Genomics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table CARTANA AB (Sweden) Profile
Table Product Overview
Table CARTANA AB (Sweden) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure CARTANA AB (Sweden) Revenue and Growth Rate
Figure CARTANA AB (Sweden) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table READCOOR, INC (U.S.) Profile
Table Product Overview
Table READCOOR, INC (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure READCOOR, INC (U.S.) Revenue and Growth Rate
Figure READCOOR, INC (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Advanced Cell Diagnostics, Inc. (U.S.) Profile
Table Product Overview
Table Advanced Cell Diagnostics, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Advanced Cell Diagnostics, Inc. (U.S.) Revenue and Growth Rate
Figure Advanced Cell Diagnostics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Dovetail Genomics (U.S.) Profile
Table Product Overview
Table Dovetail Genomics (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Dovetail Genomics (U.S.) Revenue and Growth Rate
Figure Dovetail Genomics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Novartis AG (Switzerland) Profile
Table Product Overview
Table Novartis AG (Switzerland) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Novartis AG (Switzerland) Revenue and Growth Rate
Figure Novartis AG (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Pfizer Inc. (U.S.) Profile
Table Product Overview
Table Pfizer Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer Inc. (U.S.) Revenue and Growth Rate
Figure Pfizer Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Merck & Co., Inc. (Germany) Profile
Table Product Overview
Table Merck & Co., Inc. (Germany) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Merck & Co., Inc. (Germany) Revenue and Growth Rate
Figure Merck & Co., Inc. (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Novo Nordisk A/S (Denmark) Profile
Table Product Overview
Table Novo Nordisk A/S (Denmark) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Novo Nordisk A/S (Denmark) Revenue and Growth Rate
Figure Novo Nordisk A/S (Denmark) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Amgen Inc. (U.S.) Profile
Table Product Overview
Table Amgen Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Amgen Inc. (U.S.) Revenue and Growth Rate
Figure Amgen Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Johnson & Johnson Services, Inc. (U.S.) Profile
Table Product Overview
Table Johnson & Johnson Services, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Johnson & Johnson Services, Inc. (U.S.) Revenue and Growth Rate
Figure Johnson & Johnson Services, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Gsk plc (U.K.) Profile
Table Product Overview
Table Gsk plc (U.K.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Gsk plc (U.K.) Revenue and Growth Rate
Figure Gsk plc (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bayer AG (Germany) Profile
Table Product Overview
Table Bayer AG (Germany) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Bayer AG (Germany) Revenue and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Spatial Genomics Revenue Market Size Forecast by Type (2023-2029)
Table Global Spatial Genomics Revenue Market Share Forecast by Type (2023-2029)
Table Global Spatial Genomics Revenue Market Size by Application (2023-2029)
Table Global Spatial Genomics Revenue Market Share by Application (2023-2029)
Figure Global Spatial Genomics Revenue Forecast Market Size (2023-2029)
Table Spatial Genomics Revenue Forecast Market Size by Regions (2023-2029)
Table Spatial Genomics Revenue Forecast Market Share by Regions (2023-2029)
Figure North America Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Europe Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Latin America Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Spatial Genomics Revenue Forecast Market Size (2023-2029)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|